Evidence map›Paper›PMID 39412040›Full record

ReviewCurrent opinion in pulmonary medicine2025

Bedside to bench and back again-translational research in interventional pulmonology.

Beenish Iqbal, Hee Jae Choi, Nikolaos I Kanellakis, Jason Akulian, Najib M Rahman

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current opinion in pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Beenish IqbalOxford Respiratory Trials Unit, University of Oxford, Oxford, UK.
Hee Jae ChoiPGY-5, Division of Pulmonary and Critical Care, University of North Carolina, Chapel Hill, North Carolina, USA.
Nikolaos I KanellakisChinese Oxford Institute, University of Oxford, Oxford, UK.
Jason AkulianInterventional Pulmonology and Pulmonary Oncology, Division of Pulmonary and Critical Care, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
Najib M RahmanProfessor of Respiratory Medicine, Director Oxford Respiratory Trials Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewTranslational research in Interventional Pulmonology has made significant advances in recent years, ranging from novel biomarkers and imaging to practice-changing clinical trials in lung cancer and pleural disease. This review article aims to summarize key research studies in the field to understand the latest published evidence and to highlight areas of growing academic interest. RECENT

findingsIn lung cancer, the role of novel imaging and biomarkers and their potential utility in early lung cancer diagnosis will be highlighted. In pleural disease, less invasive/conservative treatment in pneumothorax, early aggressive treatment in pleural infection along with novel biomarkers, and the shift beyond drainage strategies in malignant pleural effusion and mesothelioma will be discussed. SUMMARY: This overview of translational research in the field of interventional pulmonology will ultimately help to highlight the gaps in current evidence to promote research in areas of clinical significance.

Indexed as

Lung NeoplasmsPulmonary MedicineTranslational Research, BiomedicalBiomarkersHumansPleural DiseasesPleural Effusion, MalignantBiomarkers

Identifiers

PMID39412040
PMCPMC11623379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.